Home / Academic Researcher / Visiopharm
Visiopharm
Paid FEATURED

Visiopharm

Computational pathology software for image analysis.

Snapshot of Visiopharm
Auto-generated snapshot

Offers the HALO platform for quantitative tissue analysis. AI modules classify tumors, count mitotic figures, and quantify IHC staining in clinical and research pipelines.

PROS

  • + Reduces inter-observer variability in cancer grading and biomarker scoring
  • + Provides highly accurate and reproducible quantitative data from whole slide images
  • + Accelerates drug discovery and therapeutic development research pipelines
  • + Offers CE-IVD cleared diagnostic algorithms for clinical use in Europe
  • + Supports multi-dimensional image analysis across various tissue stains and modalities

CONS

  • - Custom/Enterprise pricing implies high upfront and ongoing operational costs
  • - Requires high-resolution digital slide images and substantial computational resources
  • - Steep learning curve for custom algorithm development compared to pre-trained apps
  • Classifying tumor morphology and immune cell infiltration using deep learning
  • Quantifying IHC and ISH staining to assess protein expression (e.g.
  • HER2) for treatment decisions
  • Automating cell counting and mitotic figure analysis in cancer grading
  • Conducting high-throughput batch analysis on Tissue Microarrays (TMAs) for research
  • Developing and validating custom AI models for novel tissue biomarkers

SIMILAR TOOLS

Weekly Intel

STAY AHEAD OF THE AI CURVE

Join 10,000+ professionals getting curated AI tool recommendations. No fluff, just actionable value.